StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
11
Publishing Date
2023 - 06 - 01
1
2023 - 03 - 17
1
2022 - 11 - 04
1
2022 - 09 - 08
1
2022 - 08 - 04
1
2022 - 05 - 06
1
2021 - 11 - 12
1
2021 - 06 - 01
1
2021 - 05 - 13
1
2021 - 03 - 16
1
2020 - 11 - 12
1
Sector
Finance
2
Health technology
11
Tags
Efruxifermin
3
Expansion
1
Financial
2
Financial results
4
Liver
1
N/a
11
Nash
1
Phase 2b
1
Presentation
1
Results
11
Therapeutics
7
Trial
2
Update
2
Year
1
Entities
Akero therapeutics, inc.
11
Hercules capital, inc.
1
Morgan stanley
1
Pfizer, inc.
1
Symbols
AKRO
11
HTGC
1
MS
1
PFE
1
Exchanges
Nasdaq
11
Nyse
2
Crawled Date
2023 - 06 - 01
1
2023 - 03 - 17
1
2022 - 11 - 04
1
2022 - 09 - 08
1
2022 - 08 - 04
1
2022 - 05 - 07
1
2021 - 11 - 14
1
2021 - 06 - 01
1
2021 - 05 - 13
1
2021 - 03 - 16
1
2021 - 02 - 24
1
Crawled Time
00:20
1
11:00
3
12:00
2
15:25
1
16:20
1
20:00
2
21:00
1
Source
apyxmedical.com
27
firstcobalt.com
19
hightideinc.com
18
investor.alkermes.com
17
investor.assemblybio.com
11
investor.aveooncology.com
15
investors.biomarin.com
15
ir.akerotx.com
11
ir.arberobotics.com
14
ir.ateapharma.com
12
ir.auriniapharma.com
20
ir.biolinerx.com
16
ir.check-cap.com
11
ir.cleverleaves.com
13
ir.iqvia.com
26
ir.kalvista.com
12
ir.servicesource.com
15
ir.sypris.com
17
ir.therapeuticsmd.com
15
ir.viveve.com
20
jaguarhealth.gcs-web.com
12
neurosense.investorroom.com
11
ocutx.gcs-web.com
15
spacfeed.com
398
velodynelidar.com
17
www.4frontventures.com
11
www.admabiologics.com
17
www.adnas.com
16
www.alnylam.com
16
www.ameresco.com
21
www.arcadiabio.com
21
www.archcapgroup.com
23
www.balchem.com
22
www.bbxcapital.com
17
www.biospace.com
7275
www.blackknightinc.com
16
www.bry.com
15
www.burcon.ca
12
www.caledoniamining.com
13
www.ceragon.com
16
www.cvdequipment.com
16
www.farmermac.com
20
www.globalp.com
17
www.globenewswire.com
23353
www.igcinc.us
11
www.kopin.com
15
www.kosmosenergy.com
15
www.lomiko.com
12
www.nanthealth.com
15
www.nexstar.tv
12
www.ooma.com
18
www.prnewswire.com
11430
www.repay.com
21
www.safebulkers.com
12
www.stagindustrial.com
17
www.sunopta.com
19
www.teekay.com
17
www.thermogenesis.com
12
www.universallogistics.com
12
www.versabank.com
13
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
results
source :
Ir.akerotx.com
save search
Akero Therapeutics to Present Results from Phase 2b Expansion Cohort of SYMMETRY Trial Evaluating Efruxifermin in Combination with GLP-1
Published:
2023-06-01
(Crawled : 20:00)
- ir.akerotx.com
AKRO
|
$21.62
-0.78%
-0.79%
820K
|
Health Technology
|
-51.71%
|
O:
0.73%
H:
3.37%
C:
2.82%
efruxifermin
expansion
trial
therapeutics
results
Akero Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
Published:
2023-03-17
(Crawled : 11:00)
- ir.akerotx.com
AKRO
|
$21.62
-0.78%
-0.79%
820K
|
Health Technology
|
-45.17%
|
O:
0.58%
H:
1.98%
C:
0.65%
year
therapeutics
financial
results
Akero Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
Published:
2022-11-04
(Crawled : 11:00)
- ir.akerotx.com
MS
|
News
0 d
|
$90.08
1.06%
-0.28%
9.5M
|
Finance
|
8.13%
|
O:
1.83%
H:
0.7%
C:
-0.35%
AKRO
|
$21.62
-0.78%
-0.79%
820K
|
Health Technology
|
-46.8%
|
O:
-0.46%
H:
4.12%
C:
-5.62%
therapeutics
financial
update
results
Akero Therapeutics to Present Results from Phase 2b HARMONY Trial Investigating Efruxifermin in Patients with Pre-Cirrhotic NASH
Published:
2022-09-08
(Crawled : 20:00)
- ir.akerotx.com
AKRO
|
$21.62
-0.78%
-0.79%
820K
|
Health Technology
|
65.33%
|
O:
-1.37%
H:
0.08%
C:
-9.92%
trial
therapeutics
results
nash
efruxifermin
phase 2b
Akero Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
Published:
2022-08-04
(Crawled : 21:00)
- ir.akerotx.com
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-48.48%
|
O:
-0.44%
H:
0.66%
C:
-0.75%
HTGC
F
|
$18.16
0.95%
-0.22%
730K
|
Finance
|
15.47%
|
O:
0.13%
H:
2.69%
C:
2.69%
AKRO
|
$21.62
-0.78%
-0.79%
820K
|
Health Technology
|
70.37%
|
O:
1.33%
H:
6.94%
C:
6.33%
therapeutics
update
results
Akero Therapeutics Reports First Quarter 2022 Financial Results
Published:
2022-05-06
(Crawled : 16:20)
- ir.akerotx.com
AKRO
|
$21.62
-0.78%
-0.79%
820K
|
Health Technology
|
91.31%
|
O:
-4.21%
H:
0.0%
C:
0.0%
therapeutics
results
Akero Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
Published:
2021-11-12
(Crawled : 00:20)
- ir.akerotx.com
AKRO
|
$21.62
-0.78%
-0.79%
820K
|
Health Technology
|
-11.39%
|
O:
0.69%
H:
0.0%
C:
0.0%
financial results
results
Akero Therapeutics to Present Efruxifermin (EFX) Results Showing Histologic Improvement in EFX-Treated F4 Cirrhotic Patients as a Late-Breaker Oral Presentation at the 2021 International Liver Congress
Published:
2021-06-01
(Crawled : 12:00)
- ir.akerotx.com
AKRO
|
$21.62
-0.78%
-0.79%
820K
|
Health Technology
|
-16.77%
|
O:
-1.72%
H:
3.93%
C:
2.29%
presentation
results
liver
efruxifermin
Akero Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
Published:
2021-05-13
(Crawled : 11:00)
- ir.akerotx.com
AKRO
|
$21.62
-0.78%
-0.79%
820K
|
Health Technology
|
-20.76%
|
O:
0.04%
H:
2.33%
C:
0.8%
financial results
results
Akero Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
Published:
2021-03-16
(Crawled : 12:00)
- ir.akerotx.com
AKRO
|
$21.62
-0.78%
-0.79%
820K
|
Health Technology
|
-33.83%
|
O:
-0.91%
H:
0.0%
C:
-2.85%
financial results
results
Akero Therapeutics Reports Third Quarter 2020 Financial Results
Published:
2020-11-12
(Crawled : 15:25)
- ir.akerotx.com
AKRO
|
$21.62
-0.78%
-0.79%
820K
|
Health Technology
|
-24.86%
|
O:
6.86%
H:
0.0%
C:
-9.97%
financial results
results
therapeutics
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.